PopulationsHumans100 participantsCross-sectional study

Association between SGLT-2 inhibitor use and retinal microvascular parameters in patients with Type 2 diabetes mellitus: A cross-sectional study

Journal of Diabetes and Its Complications

The paper

Serap Castur, Mehmet Umut Çapar, Serdar Şahin,

Lütfullah Caştur, Sevval Eksert, Busenur Gönen, Taner Damcı,

Mustafa Sait Gönen

Istanbul University-Cerrahpaşa

Journal of Diabetes and Its Complications · 24 Aug 2026

doi.org/10.1016/j.jdiacomp.2026.109394 PubMed 42664812

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026